Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: Relevance to atherogenesis, cardiovascular diseases and aging

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 3, 2014, Pages 497-514

  Shah, Nilank C ^a   Shah, Gatha J ^a   Li, Zhiqiang ^b   Jiang, Xian Cheng ^b,c   Altura, Bella T ^a,c,e   Altura, Burton M ^a,c,d,e  

^a Departments of Physiology and Pharmacology   (United States)

^b Departments of Anatomy and Cell Biology   (United States)

^c Downstate Health Sciences University   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e Bio Defense Systems Inc   (United States)

Author keywords

8 hydroxydeoxyguanosine; Cardiac muscle; Ceramide; Epigenetics; P53; Sphingolipids; Telomeres; Vascular muscle

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CERAMIDE; PROTEIN P53; SPHINGOMYELIN PHOSPHODIESTERASE; TELOMERASE;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUID INTAKE; FOOD INTAKE; MAGNESIUM BLOOD LEVEL; MAGNESIUM DEFICIENCY; MALE; NONHUMAN; NUTRITIONAL DEFICIENCY; OXIDATIVE STRESS; PHYSIOLOGY; RAT; SMOOTH MUSCLE FIBER; UPREGULATION;

EID: 84897511616     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (142)

1. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertens 2001; 38: 581-587.
2. Mulvany MJ. Small artery remodeling and significance in the development of hypertension. News Physiol Sci 2002; 17: 105-109.
3. Kumar V, Abbas AK, Fasuto N, Aster JC, editors. Robbins and Cotran Pathologic Basis of Disease. 8th edition. 2010, pp: 487-506.
4. Seelig MS. Magnesium Deficiency in the Pathogenesis of Disease. New York: Plenum 1980.
5. Altura BM, Altura BT. Magnesium: forgotten mineral in cardiovascular biology and angiogenesis. In: Nishizawa N, Morii H, Durlach J, editors. New Perspectives in Magnesium Research. 2007. pp: 239-260.
6. Altura BM, Altura BT. Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res 1995; 41: 347-359.
7. Ford ES, Mokdad AH. Dietary magnesium intake in a national sample of US adults. J Nutr 2003; 121: 2879-2882.
8. Mosfegh A, Goldman J, Abuja J, Rhodes D, LaComb R. What We Eat in America. NHANES 2005-2006: Usual Intakes from Food and Water Compared to 1997 Dietary Reference Intakes for Vitamin D, Calcium, Phosphorus, and Magnesium. Washington, DC. U.S. Department of Agricultural Research Service, 2009.
9. Altura BM, Altura BT, Gebrewold A, Ising H, Gunther T. Magnesium deficiency and hypertension: correlation between magnesium deficient diets and microcirculatory changes in situ. Scirnce 1984; 223: 1315-1317.
10. Marier JR, Neri LC. Quantifying the role of magnesium in the interrelationship between human mortality/morbidity and water hardness. Magnesium 1985; 4: 53-59.
11. Leary WP. Content of magnesium in drinking water and deaths from ishemic heart disease in white South Africans. Magnesium 1986; 5: 150-153.
12. Chipperfield B, Chipperfield JR. Relation of myocardial metal concentration to water hardness and death from ischemic heart disease. Lancet 1967; 2: 709-712.
13. Altura BM, Altura BT, Gebrewold A, Gunther T, Ising H. Noise-induced hypertension and magnesium: relationship to microcirculation and magnesium. J Appl Physiol 1992; 172: 194-202.
14. Marx A, Neutra RR. Magnesium in drinking water and deaths from ischemic heart disease. Epidemiol Rev 1997; 19: 258-272.
15. Rubenowitz E, Molin L, Axellson G, Rylander R. Magnesium in drinking water in relation to morbidity and mortality from acute myocardial infarction. Epidemiol 2003; 11: 416-421.
16. Altura BT, Brust M, Bloom S, Barbour RL, Stempak JG, Altura BM. Magnesium deficiency modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci U S A 1990; 87: 1840-1844.
17. Ouchi Y, Tabata RE, Stegiopoulos K, Sato K, Hattori A and Orimo H. Effect of dietary magnesium on development of atherosclerosis in cholesterol-fed rabbits. Arteriosclerosis 1990; 10: 732-737.
18. Ma J, Folsom AR, Melnick SL, Eckfeddt JH, Sharett AR, Nabulsi AA. Association of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. J Clin Epidemiol 1995; 48: 927-940.
19. Song Y, Manson J, Cook N, Albert C, Buring J, Liu S. Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol 2005; 96: 1135-1141.
20. King JL, Miller RJ, Blue JP Jr, O'Brien WD Jr, Erdman JW Jr. Inadequate dietary magnesium intake increases atherossclerotic plaque development in rabbits. Nutr Res 2009; 29: 343-349.
21. Amighi J, Sabeti S, Schlager O, Mlekusch W, Exner M, Labouschek W. Low serum magnesium predicts neurological events in patients with advanced atherosclerosis. Stoke 2004; 35: 22-27.
22. Turlapaty PDMV and Altura BM. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science 1980; 208: 198-200.
23. Crawford T, Crawford MD. Prevalance and pathological changes of ischemic heart disease in a hard-water area. Lancet 1967; 1: 229-232.
24. Altura BM. Ischemic heart disease and magnesium. Magnesium 1988; 7: 57-67.
25. Turlapaty PDMV, Altura BM. Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle. Eur J Pharmacol 1978; 52: 421-423.
26. Altura BM, Altura BT. Magnesium modulates calcium entry and contractility in vascular smooth muscle. In: Onishi T, Endo M, editors. The Mechanism of Gated Calcium Transport Across Biological Membranes. 1981. pp: 137-145.
27. Altura BM. Magnesium and regulation of contractility of vascular smooth muscle. Adv in Microcirculation 1982; 11: 77-113.
28. Altura BM, Altura BT. Magnesium in cardiovascular biology. Scientific Am Sci Med 1995; 2: 28-37.
29. Touyz RM. Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med 2003; 24: 107-136.
30. Gimenez MS, Oliveros LB, Gomez NN. Nutritional deficiencies and phospholipid metabolism. Int J Mol Sci 2011; 12: 2408-2433.
31. Luthringer C, Rayssiguier Y, Gueux E, Berthelot A. Effect of moderate magnesium deficiency on serum lipids, blood pressure and cardiovascular reactivity in normotensive rats. Br J Nutr 1988; 59: 243-250.
32. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium, an update on physiological, clinical and analytical aspects. Clin Chim Acta 2000; 294: 1-26.
33. Altura BT, Altura BM. Measurement of ionized magnesium in whole blood, plasma and serum with a new ion-selective electrode in healthy and diseased human subjects. Magnes Trace Elem 1991; 10: 90-98.
34. Altura BT, Memon ZI, Zhang A, Cracco RQ, Altura BM. Low levels of serum ionized magnesium are found in patients early after stroke which result in rapid elevation in cytosolic free calcium and spasm in cerebral vascular smooth muscle cells. Neurosci Lett 1997; 230: 37-40.
35. Handwerker SM, Altura BT, Royo B, Altura BM. Ionized magnesium and calcium levels in umbilical cord serum of pregnant women with transient hypertension during labor. Am J Hypertens 1993; 6: 542-545.
36. Altura BM, Altura BT. Role of magnesium and calcium in alcohol-induced hypertension and strokes as probed by in-vivo television microscopy, digital image microscopy, optical spectroscopy, 31P-NMR spectroscopy and a unique magnesium ion-sensitive electrode. Alcohol Clin Exp Res 1994; 18: 1057-1068.
37. Altura BM, Altura BT. Role of magnesium in the pathogenesis of hypertension updated: Relationship to its actions on cardiac, vascular smooth muscle, and endothelial cells. In: Laragh JH and Brenner BM, editors. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd edition. New York: Raven Press 1995. pp: 1213-1242.
38. Altura BM, Altura BT. Role of magnesium in pathophysiological processes and the clinical utility of magnesium ion selective electrodes. Scand J Clin Lab Invest 1996; 56: 211-234.
39. Markell MS, Altura BT, Barbour RL, Altura BM. Ionized and total magnesium levels in cyclosporin-treated renal transplant recipients: relationship with cholesterol and cyclosporin levels. Clin Sci 1993; 85: 315-318.
40. Markell MS, Altura BT, Sarn Y, Delano BG, Hudo O, Friedman EA, Altura BM. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis. ASAIO J 1993; 39: M801-M804.
41. Altura BM and Lewenstam A. Unique magnesium ion-selective electrodes. Scand J Clin Lab Invest 1994; 54: 1-100.
42. Resnick LM, Altura BT, Gupta RK, Alderman MH, Altura BM. Intracellular and extracellular magnesium depletion in type 2 diabetes (non-insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 767-770.
43. Bardicef M, Bardicef O, Sorokin Y, Altura BM, Altura BT, Cotton DB, Resnick LM. Extracellular and intracellular magnesium depletion in pregnancy and gestational diabetes. Am J Obstet Gynecol 1996; 172: 1009-1013.
44. Yang ZW, Gebrewold A, Nowakowski M, Altura BT, Altura BM. Mg2+-induced endothelium-dependent relaxation of blood vessels and blood pressure lowering: role of NO. Am J Physiol Regul Comp Physiol 2000; 278: R628-R639.
45. Kilililea DW, Ames BN. Magnesium deficiency accelerates cellular senescence in cultured human fibroblasts. Proc Natl Acad Sci U S A 2008; 105: 5768-5773.
46. Morrill GA, Gupta RK, Kostellow AB, Ma GY, Zhang A, Altura BT, Altura BM. Mg2+ modulates membrane lipids in vascular smooth muscle: a link to atherogenesis. FEBS Lett 1997; 408: 191-197.
47. Morrill GA, Gupta RK, Kostellow AB, Ma GY, Zhang A, Altura BT, Altura BM. Mg2+ modulates membrane sphingolipids and lipid second messengers in vascular smooth muscle cells. FEBS Lett 1998; 440: 167-171.
48. Altura BM, Shah NC, Jiang XC, Li Z, Perez-Albela JL, Sica AC, Altura BT. Short-term magnesium deficiency results in decreased levels of serum sphingomyelin, lipid peroxidation, and apoptosis in cardiovascular tissues. Am J Physiol Heart Circ Physiol 2009; 297: H86-H92.
49. Andrieu-Abadie N, Gouaze V, Salvayre R, Levade T. Ceramide in apoptosis signaling: relationship with oxidative stress. Free Radic Biol Med 2001; 31: 717-728.
50. Birbes H, Bawab SE, Hannun YA, Obeid LM. Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis. FASEB J 2001; 14: 2669-2679.
51. Hannun YA, Obeid LM. The ceramide-centric universe of lipid -mediated regulation: stress encounters of the lipid kind. J Biol Chem 2002; 277: 25847-25850.
52. Okazaki T, Bielawska AE, Bell RM, Hannun YA. Role of ceramide as a lipid mediator of 1, alpha, 25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J Biol Chem 1990; 265: 15823-15831.
53. Pandey S, Murphy RF, Agrawal DK. Recent advances in the immunobiology of ceramide. Exp Mol Pathol 2007; 82: 298-309.
54. Wyman M, Schneider R. Lipid signaling in disease. Nat Rev Mol Cell Biol 2008; 9: 162-176.
55. Hage-Sleiman R, Esmerian MO, Kobeissy H, Dbaibo G. p53 and ceramide as collaborators in the stress response. Int J Mol Sci 2013; 14: 4982-5012.
56. Aguilera-Romero A, Gehin C, Reizman H. Sphingolipid homeostatsis in the web of metabolic routes. Biochim Biophys Acta 2014; [Epub ahead of print].
57. Altura BM, Shah NC, Shah GJ, Li W, Zhang A, Zheng T, Li Z, Jiang XC, Perez-Albela JL, Altura BT. Magnesium deficiency upregulates sphingomyelinases in cardiovascular tissues and cells: cross-talk among proto-oncogenes, Mg2+, NF-kB and ceramide and their potential relationships to resistant hypertension, atherogenesis and cardiac failure. Int J Clin Exp Med 2013; 6: 861-879.
58. Fleisig HB, Wong JMY. Telomerase promotes efficient cell cycle kinetics and confers growth advantage to telomerase-negative transformed cells. Oncgene 2012; 31: 954-965.
59. Lin J, Epel E, Blackburn E. Telomeres and life style factors: Roles in cellular aging. Mutat Res 2012; 730: 85-89.
60. Wong JM, Collins K. Telomere maintenance and disease. Lancet 2003; 362: 983-988.
61. Dong CK, Mastomi K, Han WC. Telomerase: regulation, function and transformation. Crit rev Oncol Hematol 2005; 54: 85-93.
62. Matsutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB. Telomerase maintains telomere structure in normal human cells. Cell 2003; 114: 241-253.
63. Tejero-Taido MI, Chmielinska JJ, Weglicki WB. Chronic dietary Mg2+ deficiency induces cardiac apoptosis in the rat heart. Magnes Res 2007; 20: 208-212.
64. Altura BM, Gebrewold A, Altura BT, Brautbar N. Magnesium depletion impairs cardiac carbohydrate and lipid metabolism and cardiac bioenergetics and raises myocardial calcium content in vivo: relationship to etiology of cardiac diseases. Biochem Molec Biol Int 1996; 40: 1183-1190.
65. Altura BM, Gebrewold A, Zhang A, Altura BT. Low extracellular magnesium ions induces lipid peroxidation and activation of nuclear factor kB in canine cerebral vascular smooth muscle: possible relation to traumatic brain injury and strokes. Neurosci Lett 2003; 341: 189-192.
66. Wu F, Altura BT, Gao J, Barbour RL, Altura BM. Ferrylmyoglobin formation induced by acute magnesium deficiency in perfused rat heart causes cardiac failure. Biochim Biophys Acta 1994; 1225: 158-164.
67. Shah NC, Liu JP, Iqbal J, Hussain M, Jiang XC, Li Z, Li Y, Zheng T, Li W, Sica AC, Perez-Albela JL, Altura BT, Altura BT. Mg deficiency results in modulation of serum lipids, glutathione, and NO synthase isozyme activation in cardiovascular tissues: relevance to de novo synthesis of ceramide, serum Mg and atherogenesis. Int J Clin Exp Med 2011; 4: 103-118.
68. Dickens BF, Weglicki WB, Li YS, Mak IT. Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett 1992; 311: 187-191.
69. Weglicki WB, Mak IT, Kramer JH, Dickens BF, Cassidy MM. Role of free radicals and substance P in magnesium deficiency. Cardiovasc Res 1996; 31: 677-682.
70. Altura BM, Shah NC, Li Z, Jiang XC, Zhang A, Li W, Zheng T, Perez-Albela JL, Altura BT. Short-term magnesium deficiency upregulates sphingomyelin synthase and p53 in cardiovascular tissues and cells: relevance to de novo synthesis of ceramide. Am J Physiol Heart Circ Physiol 2010; 299: H2046-H2055.
71. Altura BM, Shah NC, Shah GJ, Zhang A, Li W, Zheng T, Perez-Albela JL, Altura BT. Short-term Mg-deficiency upregulates protein kinase C isoforms in cardiovascular tissues and cells; relation to NF-kB, cytokines, ceramide salvage sphingolipid pathway and PKC-zeta: hypothesis and review. Int J Clin Exp Med 2014; 6: 1-21.
72. Altura BM, Barbour RL, Dowd TL, Wu F, Altura BT, Gupta RK. Low extracellular magnesium induces intracellular free Mg deficits, depletion of high-energy phosphates and cardiac failure in intact working rat hearts: a 31P-NMR study. Biochim Biophys Acta 1993; 1182: 329-332.
73. Altura BM, Shah NC, Li Z, Jiang XC, Perez-Albela JL, Altura BT. Magnesium deficiency upregulates serine palmitoyltransferase (SPT 1 and SPT 2) in cardiovascular tissues: relationship to serum ionized Mg and cytochrome c. Am J Physiol Heart Circ Physiol 2010; 299: H932-938.
74. Altura BM, Kostellow AB, Zhang A, Li W, Morrill GA, Gupta RK, Altura BT. Expression of the nuclear factor-kB and proto-oncogenes c-fos and c-jun are induced by low extracellular Mg2+ in aortic and cerebral vascular smooth muscle cells: possible links to hypertension, atherogenesis and stroke. Am J Hypertens 2003; 16: 701-707.
75. Durlach J. Magnesium and aeging. II. Clinical data: aettiological mechanisms and pathophysiological consequences of magnesium deficiency in the elderly. Magnes Res 1993; 6: 379-394.
76. Altura BM, Shah NC, Shah GJ, Zhang A, Li W, Zheng T, Perez-Albela JL, Altura BT. Short-term magnesium deficiency upregulates ceramide synthase in cardiovascular tissues and cells: cross-talk among cytokines, Mg2+, NF-kB and de novo ceramide. Am J Physiol Heart Circ Physiol 2012; 302: H319-H332.
77. Weglicki WB. Hypomagnesemia and inflammation: Clinical and basic aspects. Annu Rev Nutr 2012; 32: 55-71.
78. Rubin H. Differences in growth requirement and retentiveness for magnesium in non-transformed and transformed mouse 3T3 cells. Magnes 1982; 1: 41-48.
79. Walker G. Magnesium and cell cycle control: an update. Magnes 1986; 5: 9-33.
80. Vernon WB. The role of magnesium in nucleic-acid and protein metabolism. Magnes 1988; 7: 234-248.
81. Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, Cherkas LF, Aviv A, Spector TD. Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662-664.
82. Babizhayev MA, Yegorov YE. Smoking and health: association between telomere length and factors impacting on human disease, quality of life and life span in a large population-based cohort under the effect of smoking duration. Fundam Clin Pharmacol 2011 Aug; 25: 425-42.
83. Nawrot TS, Staessen JA, Holvoet P, Struijker-Boudier HA, Schiffers P, Van Bortel LM, Fagard RH, Gardner JP, Kimura M, Aviv A. Telomere length and its associations with oxidized-LDL, carotid artery distensibility and smoking. Front Biosci (Elite Ed) 2010; 2: 1164-1168.
84. O'Callaghan NJ, Clifton PM, Noakes M, Fenech Ml. Weight loss in obese men is associated with increased telomere length and decreased abasic sites in rectal mucosa. Rejuvenation Res 2009; 12: 169-176.
85. Nettleton JA, Steffen LM, Palmas W, Burke GL, Jacobs DR Jr. Inverse association between adiposity and telomere length: the fels longitudinal study. Am J Human Biol 2011; 23: 100-106.
86. Nettleton JA, Steffen LM, Palmas W, Burke GL, Jacobs DR Jr. Associations between microalbuminuria and animal foods, plant foods, and dietary patterns in the Multiethnic Study of Atherosclerosis. Am J Clin Nutr 2008; 87: 1825-1826.
87. Altura BT, Shirey T, Young CC, Hiti J, Dell'Orfano K, Handwerker S, Altura BM. A method for the rapid determination of ionized Mg2+ in whole blood, serum,and plasma. Methods Find Exp Clin Pharmacol 1992 May; 14: 297-304.
88. Altura BT, Altura BM. A method for distingushing ionized, complex and protein-bound Mg in normal and diseased subjects. Scand J Clin Lab Invest 1994; 54: 83-88.
89. Altura BT, Wilimzig C, Trnovec T, Nyulassy S, Altura BM. Comparative effects of a Mg-enriched diet and different orally administered magnesium oxide preparations on ionized Mg, Mg metabolism and electrolytes in serum of human volunteers. J Am Coll Nutr 1994; 13: 447-454.
90. Memon Z, Altura BT, Benjamin JL, Cracco RQ, Altura BM. Predictive value of serum ionized but not total magnesium levels in head injuries. Scand J Clin Lab Invest 1995; 55: 671-677.
91. Handwerker S, Altura BT, Jones KY, Altura BM. Maternal-fetal transfer of ionized serum magnesium during stress of labor and delivery. J Am Coll Nutr 1995; 14: 376-381.
92. Fogh-Andersen N, Altura BM, Altura BT, Sigaard-Andersen O. Composition of interstitial fluid. Clin Chem 1995; 41: 1522-1525.
93. Scott VL, DeWolf AM, Kang Y, Altura BT, Virji MA, Cook DR, Altura BM. Ionized hypomagnesemia in patients undergoing orthotopic liver transplantation: a complication of citrate intoxication. Liver Transpl Surg 1996; 2: 343-347.
94. Fogh-Andersen N, Altura BM, Altura BT, Sigaard-Andersen O. Changes in plasma ionized calcium and magnesium in blood donors after donation of 450 ml blood. Scand J Clin Lab Invest 1996; 56: 245-250.
95. Resnick LM, Bardicef D, Altura BT, Alderman MH, Altura BM. Serum ioized magnesium: relation to blood pressure and racial factors. Am J Hypertens 1997; 10: 1420-1424.
96. Seelig MS, Altura BM. How best to determine magnesium status:a new laboratory test worth trying. Nutrition 1997; 13: 376-377.
97. Seelig MS, Altura BM. How best to determine magnesium requirement: need to consider cardiotherapeutic drugs that affect its retention. J Am Coll Nutr 1997; 16: 4-6.
98. Muneyyrici-Delale O, Nacharaju VL, Altura BM, Altura BT. Sex steroid hormones modulate serum ionized magnesium throughout the menstrual cycle in women. Fertil Steril 1998; 69: 958-962.
99. Muneyyrici-Dalale O, Nacharaju VL, Dalloul M, Altura BM, Altura BT. Serum ionized magnesium and calcium in women after menopause: inverse relationship of estrogen with ionized magnesium. Fertil Sterility 1999; 71: 869-873.
100. Djurhuus S, Henriksen JE, Klitgaard NAH, Blaaberg O, Thye-Ron P, Altura BM, Altura BT, Beck-Nielsen H. Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type I diabetes. Diabetes Care 1999; 22: 546-554.
101. Muneyyrici-Dalale O, Nacharaju VL, Altura BM, Altura BT. Serum ionized magnesium and calcium and sex hormones in healthy young men: importance of serum progesterone level. Fertil Steril 1999; 72: 817-822.
102. Muneyyrici-Dalale O, Nacharaju VL, Dalloul M, Jalou S, Rahman M, Altura BM, Altura BM, Altura BT. Divalent cations in PCOS: implications for cardiovascular disease. Gynecol Endocrinol 2001; 15: 198-201.
103. Djurhuus S, Klitgaard NAH, Pedersen KK, Blaaberg O, Altura BM, Altura BT, Henriksen JE. Magnesium reduces insulin-stimulated glucose uptake and serum lipid concentrations in type I diabetes. Metabolism 2002; 50: 1409-1417.
104. Djurhuus S, Vaag A, Altura BM, Altura BT, Klitgaard NAH. Skeletal muscle magnesium content in identical twins discordant for type 2 diabetes. Diabetes Metab 2002; 29: 201-206.
105. Altura RA, Wang WC, Wynn L, Altura BM, Altura BT. Hydroxyurea therapy associated with declining serum levels of magnesium in children with sickle cell anemia. J Pediatr 2002; 140: 565-569.
106. Zehtabchi S, Sinert R, Rinnert S, Chang B, Henis R, Altura R, Altura BT, Altura BM. Serum ionized magnesium levels and ionized calcium-to-magnesium ratios in adult patients with sickle cell anemia. Am J Hematol 2004; 77: 215-222.
107. Sinert R, Zehtabchi S, Desai S, Peacock P, Altura BT, Altura BM. Seum ionized magnesium and calcium levels in adult patients with seizures. Scand J Clin Lab Invest 2007; 67: 317-326.
108. Apostol A, Apostol R, Ali E, Choi A, Ehsuni N, Lei L, Altura BT, Altura BM. Cerebral spinal fluid and serum ionized magnesium and calcium levels in preeclamptic women during administration of magnesium sulfate. Fertil Steril 2009; 94: 276-282.
109. Li W, Zheng T, Altura BT, Altura BM. Magnesium modulates contractile responses of rat aorta to thiocyanate: A possible relationship to smoking-induced atherosclerosis. Toxicol Appl Pharmacol 1999; 157: 77-84.
110. Xu Q, Parks CG, DeRoo LA, Cawthon RM, Sandler DP, Chen Hl. Multivitamin use and telomere length in women. Am J Clin Nutr 2009; 89: 1857-1865.
111. Altura BT, Altura BM. Endothelium-dependent relaxation in coronary arteries requires magnesium ions. Br J Pharmacol 1987; 91: 449-451.
112. Maier JAM. Endothelial cells and magnesium: implications in atherosclerosis. Clin Sci 2012; 122: 397-407.
113. Grahame T, Schlesinger RB. Oxidative stress-induced telomeric erosion as a mechanism underlying airborne particulate matter-related cardiovascular disease. Part Fibre Toxicol 2012; 9: 21.
114. Wolf FI, Cittadini A. Magnesium in cell proliferation and differentiation. Front Biosci 1999; 4: d607-617.
115. Ogretmen B, Kraveka JM, Schady D, Ustal J, Hannun YA. Molecular mechanisms of ceramide-induced telomerase inhibition in the A549 human lung adenocarcinoma cell line. J Biol Chem 2002; 276: 32506-32514.
116. Ogretmen B, Pettus BJ, Rossi MJ, Wood R, Ustal J, Szulc Z, Bielawska A, Obeid LM, Hannun YA. Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in A549 human lung adenocarcinoma cell line. J Biol Chem 2002; 277: 12960-12969.
117. Voelker DR, Kennedy EP. Cellular and enzymatic synthesis of sphingomyelin. Biochem 1982; 21: 2753-2759.
118. Meek DK. Tumor suppression by p53: a role for DNA damage response? Nat Rev Cancer 2009; 9: 714-723.
119. Menendez D, Inga A, Resnick MA. The expanding universe of p53 targets. Nat Rev Cancer 2009; 9: 724-737.
120. Crivello NA, Rosenberg IH, Dallal GE, Bielinski D, Joseph JA. Age-related changes in neutral sphingomyelin-specific phospholipase C activity in striatum, hippocampus, and frontal cortex: Implication for sensitivity to stress and inflammation. Neurochem 2005; 47: 573-579.
121. Altura BM, Altura BT. Magnesium as an extracellular signal in cardiovascular pathobiology. Jap J Soc Magnes Res 1996; 15: 17-32.
122. Altura BM, Altura BT. Magnesium and contraction of arterial smooth muscle. Microvasc Res 1974; 7: 145-155.
123. Altura BT, Altura BM. Withdrawal of magnesium causes vasospasm while elevated magnesium produces relaxation of tone in cerebral arteries. Neurosci Lett 1980; 20: 323-327.
124. Altura BM, Altura BT. Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases. Federation Proc 1981; 40: 2672-2679.
125. Zhang A, Cheng TPO, Altura BM. Magnesium regulates intracellular free ionized calcium concentration and cell geometry in vascular smooth muscle cells. Biochim Biophys Acta 1992; 1134: 25-29.
126. Zhang A, Cheng TPO, Altura BT, Altura BM. Mg2+ and caffeine-induced intracellular Ca2+ release in human vascular endothelial cells. Br J Pharmacol 1993; 109: 291-292.
127. Wu F, Zou LY, Altura BT, Barbour RL, Altura BM. Low extracellular magnesium results in cardiac failure in isolated perfused hearts. Magnes Trace Elem 1992; 10: 364-373.
128. Friedman HS, Nguyen TN, Mokroaui AM, Barbour RL, Murakawa T, Altura BM. Effects of magnesium chloride on cardiovascular dynamics in the neurally intact dog. J Parmacol Exp Ther 1987; 243: 126-130.
129. Delpiano M, Altura BM. Modulatory effect of extracellular Mg2+ ions on K+ and Ca2+ currents of capillary endothelial cells. FEBS Lett 1996; 394: 335-339.
130. Zhang A, Cheng TP-O, Wu XY, Altura BT, Altura BM. Extracellular Mg2+ regulates intracellular Mg2+ and its subcellular compartmentation in fission yeast, Schizosaccharomyces pombe, Cell Molec Life Sci 1997; 53: 69-72.
131. Yang ZW, Wang J, Altura BT, Altura BM. Extracellular magnesium deficiency induces contraction ofarterial muscle: role of PI3-kinases and MAPK signaling pathways. Pfliug Arch European J Physiol 2000; 439: 240-247.
132. Yang ZW, Wang J, Zheng T, Altura BT, Altura BM. Low extracellular Mg2+ induces contraction and [Ca2+]i rises in cerebral arteries: roles of Ca2+, PKC and PI-3 kinases. Am J Physiol Heart Circ Physiol 2000; 279: H2898-H2907.
133. Yang ZW, Wang J, Zheng T, Altura BT, Altura BM. Low extracellular Mg induces contraction of cerebral arteries:roles of tyrosine and mitogen-activated protein kinases. Am J Physiol Heart Circ Physiol 2000; 279: H185-H194.
134. Zheng T, Li W, Altura BT, Shah NC, Altura BM. Sphingolipids regulate [Mg2+]o uptake and [Mg2+]i content in vacular smooth muscle cells: potential mechanisms and importance to membrane transport of Mg2+. Am J Physiol Heart Circ Physiol 2011; 300: H486-H492.
135. Hannun YA, Obeid LM. The ceramide-centric universe of lipid-mediated regulation: stress encounters of the lipid kind. J Biol Chem 2002; 277: 25847-25850.
136. Villani M, Suathra M, Im VH, Choi Y, Signorelli P, Del Poeta M, Luberto C. Sphingomyelin sunthases regulate production of diacylglycerol at the Golgi. Biochem J 2008; 414: 31-41.
137. Mercer J, Mahmoundi M, Bennett M. DNA damage, p53, apoptosis and vascular disease. Mutat Res 2007; 621: 724-737.
138. Dbalbo GS, Pushkareva MY, Rachid RA, Alter N, Smyth MJ, Obeid LM, Hannun YA. A p53-dependent ceramide response to genotoxic stress. J Clin Invest 1998; 102: 329-339.
139. Vousden KH, Ryan KM. P53 and metabolism. Nat Rev Cancer 2009; 9: 691-700.
140. Katada S, Imhof A, Sasson-Corsi P. Connecting threads: Epigenetics and metabolism. Cell 2012; 148: 24-28.
141. Lu C, Thompson CB. Metabolic regulation of epigenetics. Cell Metabolism 2012; 16: 9-17.
142. Bartel DP. MicroRNAS: target recognition and regulatory functions. Cell 2009; 136: 215-233.